Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product defect recall alert
Huvepharma N.V have contacted wholesale dealers and veterinary surgeons to examine inventory immediately.

Gallifen 200 mg/ml Suspension and Pigfen 200 mg/ml Suspension.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for two products manufactured by Huvepharma N.V.

The recall affects the following finished products from the UK market:

  • two batches of Gallifen 200 mg/ml Suspension for Use in Drinking Water for Chickens and Pheasants
  • six batches of Pigfen 200 mg/ml Suspension for Use in Drinking Water for Pigs.

The VMD writes: 'Fenbendazole content has been found lower than the agreed specification limit and sediment/caking layer is present on bottom of the bottle...Huvepharma N.V have contacted wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.'

The recall affects the following batches only:
 

Product
Batch No.
Expiry date
Gallifen 200mg/ml 19041748008 31/10/2021
Gallifen 200mg/ml 19091748023 30/03/2022
Pigfen 200mg/ml 18061747014 31/12/2020
Pigfen 200mg/ml 18091747020 30/03/2021
Pigfen 200mg/ml 19011747001 31/07/2021
Pigfen 200mg/ml 19031747019 30/09/2021


Further details can be obtained from Laura Kappelle Laura.Kappelle@huvepharma.com

 

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.